Dr. Ranjit Singh Kali-rai, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45372 Whitetail Ct, Fremont, CA 94539 Phone: 510-600-5125 |
Heumin Li, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-248-7577 |
Rahat Katyal, RPH Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 790 Saltillo Pl, Fremont, CA 94536 Phone: 510-796-0884 Fax: 510-562-5194 |
Frances Tan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 779 Emerson Ct, Fremont, CA 94539 Phone: 408-966-9696 |
Priti Chatwani Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 41766 Covington Dr, Fremont, CA 94539 Phone: 510-754-6479 |
Kandie Ann Rago, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4020 Fremont Hub, Fremont, CA 94538 Phone: 510-791-9108 |
Sejal Parikh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3860 Decoto Rd, Fremont, CA 94555 Phone: 510-793-9798 |
Rebecca Lao Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 46844 Mission Blvd, Fremont, CA 94539 Phone: 510-661-0167 |
Dr. Stella Betelia, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 43621 Pacific Commons Blvd, Fremont, CA 94538 Phone: 510-897-1119 |
Nitin Vamsy Nuthikattu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4020 Fremont Hub, Fremont, CA 94538 Phone: 510-676-9022 |
Ms. Irene Ie-ling Li, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3744 Mowry Ave, Fremont, CA 94538 Phone: 510-796-2497 Fax: 510-796-1322 |
Dr. Kevin Leung, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36 Montevideo Cir, Fremont, CA 94539 Phone: 510-656-6885 |
Xiaoming Zhang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 37323 Fremont Blvd, Fremont, CA 94536 Phone: 510-797-2772 |
Nishi Shahi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1934 Vinehill Circle, Fremont, CA 94539 Phone: 510-657-8669 |
Loan Hoang Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-248-3000 |
Dr. Delinna Dieu Huynh, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 43950 Pacific Commons Blvd, Fremont, CA 94538 Phone: 510-771-1617 |
Trinity Truong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-248-3000 |
Dr. Gurpartap Singh Basrai, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 37323 Fremont Blvd, Fremont, CA 94536 Phone: 510-797-2772 Fax: 510-797-4986 |
Janet Hanh Le, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 Mowry Ave, Fremont, CA 94538 Phone: 510-742-9356 Fax: 510-742-9386 |
Donald Lew Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39200 Paseo Padre Pkwy, Raleys Pharmacy, Fremont, CA 94538 Phone: 510-791-0657 Fax: 510-791-2673 |
News Archive
A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients.
Aeterna Zentaris Inc. today announced Phase 2 data presented for the first time on perifosine, its lead novel oral anti-cancer compound, showing promising clinical activity, safety and tolerability in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). The data were presented over the weekend at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida.
Research from Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health shows no significant decline in indoor tanning rates among children under age 17 following a ban on such use in New Jersey enacted in 2013.
Cell Therapeutics, Inc. (CTI) today announced that the Company has initiated clinical trial sites and began enrolling patients in a Phase 3 clinical trial, known as PERSIST-1 or PAC325, for pacritinib, CTI's investigational JAK2 inhibitor, which is being evaluated for the treatment of patients with myelofibrosis.
› Verified 5 days ago